gvtcx

Ustekinumab

key details

Value£9,489,301 (£11,387,161 inc. VAT)
Statuscomplete
Category (CPV) 33600000
RegionWales
Deadline9 Mar 2026
Procedureopen
SME suitableYes
OCIDocds-h6vhtk-05f601

Awards (6)

This procurement was awarded to 6 suppliers. Values shown are per-award; the notice total is £9,489,301.

SupplierValueDateStatus
Amgen Ltd shared £6,532,463 3 Jun 2026 pending
Celltrion Healthcare shared £6,532,463 3 Jun 2026 pending
Fresenius Kabi Ltd shared £6,532,463 3 Jun 2026 pending
Gedeon Richter shared £6,532,463 3 Jun 2026 pending
Sandoz Ltd shared £6,532,463 3 Jun 2026 pending
Thornton & Ross shared £6,532,463 3 Jun 2026 pending

description

Supply of Ustekinumab

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

3 notices published against this procurement.

PublishedTypeRegimeNotice
15 Dec 2025 Preliminary market engagement (UK2) Procurement Act 2023 083013-2025
2 Feb 2026 Tender notice (UK4) Procurement Act 2023 009100-2026
15 Jun 2026 Contract award (UK6) Procurement Act 2023 056148-2026

more from NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.